Effect of hemostatics used during operations for digestive organ on cancer cells present in the peritoneal cavity

Cancer Biotherapy and Radiopharmaceuticals

Volumn 15, Issue 1, 2000, Pages 47-52

  Kubota, Nobuhiro ^a   Kojima, Takashi ^a   Naruse, Takayoshi ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FIBRIN GLUE; GELATIN SPONGE; MICROCRYSTALLINE COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL CULTURE; CELL PROLIFERATION; FEMALE; GASTROINTESTINAL SURGERY; MOUSE; NONHUMAN; PERITONEUM CANCER; PRIORITY JOURNAL; SPONGE;

EID: 0033976334     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2000.15.47     Document Type: Article

References (9)

1. Tokunaga Y, Kojima T, Naruse T. Antitumor effect of oxycellulose as a hemostatic during operation. Cancer Biother & Radiopharm 1998;13(6):437.
2. Matsuoka H, Yano K, Katsuta Y, et al. Advantages and safety of local treatment with MMC/Beriplast P for cancer tumors. Cancer Chemother Pharmacol 1996;38:508.
3. Nakajima M, Kamei T, Tomimatu K, et al. An intraperitoneal tumorous mass caused by granulomas of microfibrillar collagen hemostat (Avitene). Arch Pathol Lab Med 1995;119:1161.
4. Tsuda H, Higashi S, Iwanaga S, et al. Development of antitissue factor antibodies in patients after liver surgery. Blood 1993;82(1):96.
5. Jenkins HP, Janda R, Clarke J. Clinical and experimental observations on the use of gelatin sponge or foam. Surgery 1946;20:124.
6. Okada F, Hosokawa M, Hamada JI, et al. Malignant progression of a mouse fibrosarcoma by host cells reactive to foreign body (gelatin sponge). Br J Cancer 1992;66:635.
7. Middleton MM, Campbell PA. Functions of purified mouse neutrophils isolated from gelatin sponges. J Leukocyte Biol 1989;46:461.
8. Akporiaye ET, Kudalore MK. Implantation of a gelatin sponge as a model for effector recruitment: tumor growth inhibition by T-lymphocytes recovered from a site of tumor rejection. Cancer Immunol Immunother 1989;29:199.
9. Ascher NA, Eerguson RM, Hoffman R, et al. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 1979;27:254.